Related Experiment Video
Updated: Jun 10, 2026
09:12
Isolation of Adeno-Associated Viral Vectors Through a Single-Step and Semi-Automated Heparin Affinity Chromatography Protocol
Published on: April 5, 2024
[A novel packaging system of recombinant AAV5/5 vector]
Xiaoyan Dong1, Wenhong Tian, Zhenhua Yuan
1State Key Laboratory for Molecular Virology and Genetic Engineering, Institute for Viral Disease Prevention and Control, Chinese Center for Disease Prevention and Control, Beijing 100052, China.
Summary
We established a scalable adeno-associated virus type 5 (AAV5/5) vector production system using a recombinant herpes simplex virus type 1 (HSV1) helper virus. This efficient system enables large-scale production of AAV5/5 vectors for gene therapy research.
Area of Science:
- Molecular Biology
- Virology
- Gene Therapy
Context:
- Adeno-associated virus (AAV) vectors are crucial tools for gene therapy.
- Developing scalable and efficient production systems for specific AAV serotypes, like AAV5, is essential for clinical applications.
- Existing methods for AAV production can be limited in scalability and efficiency.
Purpose:
- To develop a scalable and efficient packaging system for adeno-associated virus type 5 (AAV5/5) vectors.
- To create a helper virus based on recombinant herpes simplex virus type 1 (HSV1) carrying AAV5 rep and cap genes.
- To establish a production cell line for high-yield generation of recombinant AAV5/5 vectors.
Summary:
- A novel AAV5/5 vector packaging system was developed using a replication-competent recombinant HSV1 (rHSV1-rep5cap5) as a helper virus.
- A production cell line (C020) was established by transfecting BHK21 cells and selecting for high-efficiency rAAV5/5-EGFP production.
- Recombinant AAV5/5 vectors (rAAV5/5-EGFP) were produced, purified using ultrafiltration, and characterized by SDS-PAGE and transmission electron microscopy, demonstrating high purity and particle integrity.
- Functional assays showed that the produced rAAV5/5-EGFP vectors could transduce HEK293 cells, indicating their potential for gene delivery.
Impact:
- Establishes an efficient and scalable AAV5/5 vector production system.
- Provides a method for large-scale production of recombinant AAV5/5 viruses, facilitating gene therapy research.
- Characterization of the produced vectors confirms their purity and suitability for further studies.
